Nektar Therapeutics (NASDAQ: NKTR) reported that partner AstraZeneca (NYSE: AZN) announced that MOVANTIK (naloxegol) has launched in the United States ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE